146 related articles for article (PubMed ID: 36964435)
1. A three-marker signature identifies senescence in human breast cancer exposed to neoadjuvant chemotherapy.
El-Sadoni M; Shboul SA; Alhesa A; Shahin NA; Alsharaiah E; Ismail MA; Ababneh NA; Alotaibi MR; Azab B; Saleh T
Cancer Chemother Pharmacol; 2023 Apr; 91(4):345-360. PubMed ID: 36964435
[TBL] [Abstract][Full Text] [Related]
2. Expression of therapy-induced senescence markers in breast cancer samples upon incomplete response to neoadjuvant chemotherapy.
Saleh T; Alhesa A; Al-Balas M; Abuelaish O; Mansour A; Awad H; El-Sadoni M; Carpenter VJ; Azab B
Biosci Rep; 2021 May; 41(5):. PubMed ID: 33948615
[TBL] [Abstract][Full Text] [Related]
3. NOXA expression is downregulated in human breast cancer undergoing incomplete pathological response and senescence after neoadjuvant chemotherapy.
Al Shboul S; El-Sadoni M; Alhesa A; Abu Shahin N; Abuquteish D; Abu Al Karsaneh O; Alsharaiah E; Ismail MA; Tyutyunyk-Massey L; Alotaibi MR; Neely V; Harada H; Saleh T
Sci Rep; 2023 Sep; 13(1):15903. PubMed ID: 37741850
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the expression of P16INK4A by immunohistochemistry in post-neoadjuvant chemotherapy hormone receptor negative breast cancer specimens.
Febres-Aldana CA; Kuritzky N; Krishnamurthy K; Poppiti R; Howard L
Breast Dis; 2020; 39(2):51-59. PubMed ID: 31839602
[TBL] [Abstract][Full Text] [Related]
5. Therapy-induced senescence as a component of tumor biology: Evidence from clinical cancer.
Saleh T; Bloukh S; Hasan M; Al Shboul S
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188994. PubMed ID: 37806641
[TBL] [Abstract][Full Text] [Related]
6. The Expression of the Senescence-Associated Biomarker Lamin B1 in Human Breast Cancer.
Saleh T; Alhesa A; El-Sadoni M; Abu Shahin N; Alsharaiah E; Al Shboul S; Awad H; Bloukh S; Al-Balas M; Alsalem M; Azab B; Aladily TN
Diagnostics (Basel); 2022 Feb; 12(3):. PubMed ID: 35328162
[TBL] [Abstract][Full Text] [Related]
7. RB-pathway disruption is associated with improved response to neoadjuvant chemotherapy in breast cancer.
Witkiewicz AK; Ertel A; McFalls J; Valsecchi ME; Schwartz G; Knudsen ES
Clin Cancer Res; 2012 Sep; 18(18):5110-22. PubMed ID: 22811582
[TBL] [Abstract][Full Text] [Related]
8. Therapy-induced senescent cancer cells exhibit complement activation and increased complement regulatory protein expression.
Abu-Humaidan AH; Ismail MA; Ahmad FM; Al Shboul S; Barham R; Tadros JS; Alhesa A; El-Sadoni M; Alotaibi MR; Ababneh NA; Saleh T
Immunol Cell Biol; 2024 Apr; 102(4):240-255. PubMed ID: 38265162
[TBL] [Abstract][Full Text] [Related]
9. Effect of cytotoxic chemotherapy on markers of molecular age in patients with breast cancer.
Sanoff HK; Deal AM; Krishnamurthy J; Torrice C; Dillon P; Sorrentino J; Ibrahim JG; Jolly TA; Williams G; Carey LA; Drobish A; Gordon BB; Alston S; Hurria A; Kleinhans K; Rudolph KL; Sharpless NE; Muss HB
J Natl Cancer Inst; 2014 Apr; 106(4):dju057. PubMed ID: 24681605
[TBL] [Abstract][Full Text] [Related]
10. Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse.
Demaria M; O'Leary MN; Chang J; Shao L; Liu S; Alimirah F; Koenig K; Le C; Mitin N; Deal AM; Alston S; Academia EC; Kilmarx S; Valdovinos A; Wang B; de Bruin A; Kennedy BK; Melov S; Zhou D; Sharpless NE; Muss H; Campisi J
Cancer Discov; 2017 Feb; 7(2):165-176. PubMed ID: 27979832
[TBL] [Abstract][Full Text] [Related]
11. Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy.
Ács B; Zámbó V; Vízkeleti L; Szász AM; Madaras L; Szentmártoni G; Tőkés T; Molnár BÁ; Molnár IA; Vári-Kakas S; Kulka J; Tőkés AM
Diagn Pathol; 2017 Feb; 12(1):20. PubMed ID: 28222768
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Therapeutic Target Gene Expression Based on Residual Cancer Burden Classification After Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer.
Takahashi Y; Iwamoto T; Suzuki Y; Kajiwara Y; Hatono M; Tsukioki T; Kawada K; Kochi M; Ikeda H; Shien T; Taira N; Matsuoka J; Doihara H; Toyooka S
Clin Breast Cancer; 2020 Apr; 20(2):117-124.e4. PubMed ID: 31570267
[TBL] [Abstract][Full Text] [Related]
13. Protein and chemotherapy profiling of extracellular vesicles harvested from therapeutic induced senescent triple negative breast cancer cells.
Kavanagh EL; Lindsay S; Halasz M; Gubbins LC; Weiner-Gorzel K; Guang MHZ; McGoldrick A; Collins E; Henry M; Blanco-Fernández A; O Gorman P; Fitzpatrick P; Higgins MJ; Dowling P; McCann A
Oncogenesis; 2017 Oct; 6(10):e388. PubMed ID: 28991260
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
[TBL] [Abstract][Full Text] [Related]
15. Ratio of proliferation markers and HSP90 gene expression as a predictor of pathological complete response in breast cancer neoadjuvant chemotherapy.
Jarzab M; Kowal M; Bal W; Oczko-Wojciechowska M; Rembak-Szynkiewicz J; Kowalska M; Stobiecka E; Chmielik E; Tyszkiewicz T; Kaszuba M; Nowicka E; Lange B; Czarniecka A; Krajewska J; Dyla A; Dobrut M; Lange D; Jarzab B; Bobek-Billewicz B; Tarnawski R
Folia Histochem Cytobiol; 2016; 54(4):202-209. PubMed ID: 28051275
[TBL] [Abstract][Full Text] [Related]
16. A prognostic model based on combining estrogen receptor expression and Ki-67 value after neoadjuvant chemotherapy predicts clinical outcome in locally advanced breast cancer: extension and analysis of a previously reported cohort of patients.
Miglietta L; Morabito F; Provinciali N; Canobbio L; Meszaros P; Naso C; Murialdo R; Boitano M; Salvi S; Ferrarini M
Eur J Surg Oncol; 2013 Oct; 39(10):1046-52. PubMed ID: 23890870
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of senescence markers p14(ARF) and p16(INK4a) in breast cancer is associated with an increased risk of disease recurrence and poor survival outcome.
Pare R; Shin JS; Lee CS
Histopathology; 2016 Sep; 69(3):479-91. PubMed ID: 26843058
[TBL] [Abstract][Full Text] [Related]
18. Curcumin triggers p16-dependent senescence in active breast cancer-associated fibroblasts and suppresses their paracrine procarcinogenic effects.
Hendrayani SF; Al-Khalaf HH; Aboussekhra A
Neoplasia; 2013 Jun; 15(6):631-40. PubMed ID: 23730211
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of Ki67 expression in HR-negative breast cancer before and after neoadjuvant chemotherapy.
Tan QX; Qin QH; Yang WP; Mo QG; Wei CY
Int J Clin Exp Pathol; 2014; 7(10):6862-70. PubMed ID: 25400769
[TBL] [Abstract][Full Text] [Related]
20. DNA Damage- But Not Enzalutamide-Induced Senescence in Prostate Cancer Promotes Senolytic Bcl-xL Inhibitor Sensitivity.
Malaquin N; Vancayseele A; Gilbert S; Antenor-Habazac L; Olivier MA; Ait Ali Brahem Z; Saad F; Delouya G; Rodier F
Cells; 2020 Jul; 9(7):. PubMed ID: 32630281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
